BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems, has prevailed in its patent battle with Nomos. BrainLAB announced Feb. 9 that the U.S. Court of Appeals for the Federal Circuit in Washington, DC, has upheld a
BrainLAB, a developer of image-guided surgery (IGS) and stereotactic radiosurgery systems, has prevailed in its patent battle with Nomos. BrainLAB announced Feb. 9 that the U.S. Court of Appeals for the Federal Circuit in Washington, DC, has upheld a lower court ruling that BrainLAB's ExacTrac product does not infringe U.S. patent 5,411,026 for Nomos' BAT ultrasound-based target locating device. ExacTrac is BrainLAB's patient positioning system for the treatment of tumors with stereotactic radiotherapy/radiosurgery. The system's ultrasound localization allows a daily verification of the position of organs, such as the prostate or liver, which improves the precision of radiotherapy by allowing adjustments for shifts in organ position.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.